US equities |
MU $983.23 ▲+5.86% META $612.49 ▼-1.24% GOOGL $324.89 ▲+1.34% NVDA $215.38 ▼-1.17% MSFT $531.01 ▼-0.06% TSLA $404.22 ▼-0.80% SPCX $145.23 ▼-2.25% SNDK $1,404.77 ▲+7.66%
FinancialContent

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.470 +0.050 (+3.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Announces Participation in 2026 BIO International Convention
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model
From Enveric Biosciences
Via Business Wire
These stocks are moving in today's session ↗
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
SmallCap Emerge: ENVB, SMX, ANY, ELPW Across High-Growth Sectors
Via AB Newswire
Topics Artificial Intelligence Economy
Top movers analysis one hour before the close of the markets on 2026-04-24: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum
From Enveric Biosciences
Via Business Wire
News headline image
Kartoon Studios (NYSE: TOON) Gaining Momentum Alongside CMND, ENVB, WLDS, ANY – See Why?
Via AB Newswire
Topics Intellectual Property
Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
Unusual volume stocks are being observed in Monday's session. ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Top movers in Monday's pre-market session ↗
Via Chartmill
News headline image
Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules
From Enveric Biosciences, Inc.
Via Business Wire
Which stocks are experiencing notable movement on Friday? ↗
Via Chartmill
These stocks have an unusual volume in today's session ↗
Via Chartmill
Friday's session: top gainers and losers ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >